SCHEMBL20819536

SCHEMBL20819536

COc1cc(C)c(C)c(C)c1C1(C(=O)O)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ GFER P55789 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ GPR35 Q9HC97 1/20 0.36
▸ LMNA P02545 2/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ PDE4D Q08499 1/20 0.34
▸ HSD17B10 Q99714 2/20 0.33
▸ AKR1B10 O60218 1/20 0.33
▸ AKR1C4 P17516 1/20 0.33
▸ AKR1C3 P42330 1/20 0.33
▸ AKR1C2 P52895 1/20 0.33
▸ AKR1C1 Q04828 1/20 0.33
▸ CA12 O43570 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20819549 0.88 HPGD (0.40) CYP3A4MEN1KMT2ANPSR1HPGD
SCHEMBL20819606 0.86 LCK (0.35) CYP3A4MEN1KMT2ANPSR1HPGD
SCHEMBL20819563 0.83 HSD17B10 (0.32) MEN1KMT2ANPSR1HPGDMAPT
SCHEMBL20819588 0.81 ALDH1A1 (0.45) MEN1KMT2ANPSR1LMNAL3MBTL1
SCHEMBL20819553 0.81 ALDH1A1 (0.41) MEN1KMT2AMAPTLMNAL3MBTL1
SCHEMBL20790295 0.81 LMNA (0.40) MEN1KMT2AHPGDPOLBMAPT
SCHEMBL31045607 0.79 MAP3K14 (0.41) MEN1KMT2AHPGDPOLBMAPT
SCHEMBL20819738 0.77 RXRA (0.36) MEN1KMT2ANPSR1MAPTGPR35
SCHEMBL20819590 0.76 ALDH1A1 (0.41) KMT2APOLBMAPTCA12CA1
SCHEMBL20819534 0.75 KDM4E (0.39) MEN1KMT2ANPSR1MAPTGPR35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3681864-A1 MODULATORS OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN AND METHODS OF USE AbbVie Overseas S.à r.l. (LU) 2020-07-22 — — EP disclosed
WO-2019053634-A1 MODULATORS OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN AND METHODS OF USE AbbVie S.à.r.l. (LU) 2019-03-21 — — WO disclosed
Send feedback